Analytical testing, QC

Lonza uses its ‘global footprint’ in hematopoietic commercialization agreement

21-Feb-2019 By Maggie Lynch

Lonza enters private label partnership to manufacture and globally commercialize AllCell’s hematopoietic primary cells to provide greater access to researchers.

‘Just a few mouse clicks’: TriNetX offers RWD analytics

21-Feb-2019 By Maggie Lynch

Global health research network, TriNetX, has added an analytic self-service offering for simplified analysis of real-world data.

PPD signs exclusive agreement with China-based AI company

21-Feb-2019 By Melissa Fassbender

PPD’s agreement with China-based Happy Life Tech focuses on site selection, patient recruitment, and real-world evidence generation for customers globally.

LabNetwork reaches European customers through marketplace collaboration

19-Feb-2019 By Maggie Lynch

Chemspace and LabNetwork, both online marketplaces, are to collaborate to extend their global reach in the online marketplace.

SCOPE 2019

Saama adds new AI-based capabilities to its analytics platform

18-Feb-2019 By Melissa Fassbender

Saama Technologies today unveiled three new machine learning-based capabilities, extending the functionality of its life science analytics cloud.

Charles River to acquire Citoxlab, M&A ‘a top priority’

14-Feb-2019 By Melissa Fassbender

Charles River is set to acquire Citoxlab for €448m ($510m) in cash, a deal which would bolster the CRO’s safety assessment portfolio to support its long-term organic growth aspirations, says CEO.

People on the Move: Outsourcing-Pharma roundup January '19

08-Feb-2019 By Melissa Fassbender

People on the move in January include new CEOs at Lonza, Taconic, MaSTherCell, Pii, and Wasdell, among several other c-suite shakeups and new hires as the industry kicks off the New Year.

Exclusive interview

QPS triples translational medicine capacity to support gene therapy demand

05-Feb-2019 By Melissa Fassbender

QPS is expanding ‘aggressively’ at its US-based headquarters, rebuilding on a rolling basis to support a growing demand for gene therapy treatments, says VP.

A Game of Partnerships: How does the BMS-Celgene merger affect the CRO space?

01-Feb-2019 By Melissa Fassbender

CRO stock prices fell initially following the news that Bristol-Myers Squibb was acquiring Celgene in a deal valued at $74bn. However, is 2019’s first mega-merger really a threat to service providers?

Repositive’s ‘personal shopper’ aims to ease access to its cancer models

31-Jan-2019 By Maggie Lynch

Repositive adds a personal shopper service to its platform which holds a directory of cancer models from 14 CROs – with expansion ongoing, says CEO.

Charles River expanding assay lineup via Toxys tie-up

31-Jan-2019 By Melissa Fassbender

Charles River is offering Toxys’ ToxTracker in an agreement that will see its portfolio of genetic toxicology assays expand to customers in North America.

India-based CRO enters US market to support global research

31-Jan-2019 By Melissa Fassbender

Lambda Therapeutic Research is extending its global footprint to the US with the acquisition of Novum Pharmaceutical Research Services, a CRO based in Pittsburgh, PA.

SGS invests £7.6m to up testing capabilities

29-Jan-2019 By Melissa Fassbender

The contract solutions provider today announced that it has invested £7.6m ($9.99m) at its Glasgow, UK-based facility.

Wasdell gets HPRA nod at its new EU headquarters

28-Jan-2019 By Melissa Fassbender

The Wasdell Group’s new EU headquarters in Dundalk, Ireland is set to commence operations later this year as part of the company’s “proactive contingency plan” ahead of Brexit.

Sartorius Stedim BioOutsource adds NBE product characterization to service lineup

24-Jan-2019 By Melissa Fassbender

Sartorius Stedim Biotech’s contract testing subsidiary is adding services offer increased support to clients developing new biological entities.